Table 2. Inhibition Zone (mm) and MIC (μg mL–1) of the Tested Compounds (14b, 14c, 14d, 18, 27a, and 27b) in the Case of Antibacterial Activity.
| sample
no. |
|||||||
|---|---|---|---|---|---|---|---|
| bacteria strains | 14b | 14c | 14d | 18 | 27a | 27b | refa |
| S. aureus (+ve) | 11b(9.0)c | 15(7.0) | 17(7.0) | 13(8.0) | 14 (7.0) | 15(8.0) | 18(5.0) |
| B. cereus (+ve) | 10(8.0) | 18(7.0) | 15(8.0) | 11(8.0) | 12(7.0) | 13(7.0) | 22(4.0) |
| M. luteus (+ve) | 8(9.0) | 13(8.0) | 18(8.0) | 13(7.0) | 14(8.0) | 12(9.0) | 20(4.0) |
| E. coli (−ve) | 8(10) | 16(8.0) | 16(7.0) | 10(9.0) | 13(8.0) | 14(8.0) | 18(5.0) |
| P. aeruginosa (−ve) | 10(9.0) | 15(8.0) | 17(8.0) | 12(9.0) | 13(10) | 15(8.0) | 18(5.0) |
| S. marcescens (−ve) | 8(8.0) | 17(7.0) | 19(7.0) | 14(8.0) | 12(9.0) | 11(7.0) | 20(3.0) |
a
Ref = chloramphenicol as antibacterial reference; amount added to each pore = 50 μL.
b
The diameter of inhibition zone in (mm) of compounds (14b, 14c, 14d, 18, 27a, and 27b).
c
MIC (minimum inhibition concentration) in (μg mL–1) of compounds (14b, 14c, 14d, 18, 27a, and 27b).